Effect of L/N-type Calcium Channel Blocker (Cilnidipine) on Oxidative Stress in Nitric Oxide-deficient Hypertensive Rats

被引:0
|
作者
Shaikh, Gouher B. [1 ]
Hippargi, Surekha [2 ]
Majid, Dewan S. A. [3 ]
Biradar, M. S. [4 ]
Das, Kusal K. [1 ]
机构
[1] Tulane Univ, Lab Vasc Physiol & Med, Dept Physiol, New Orleans, LA 70118 USA
[2] Tulane Univ, Dept Pathol, New Orleans, LA 70118 USA
[3] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[4] BLDE Deemed Be Univ, Shri BM Patil Med Coll Hosp & Res Ctr, Dept Med, Vijayapura 586103, Karnataka, India
关键词
Nitric Oxide Deficient Hypertension; Oxidative Stress; Mean Arterial Pressure; Malondialdehyde;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The sympathetic nervous system plays a major role on the renal function through the vasoactive system and the renin-angiotensin aldosterone system. Even though interest in the renal protective effects of sympathetic blocker has been increased, there are not much data to clarify this efficiency in nitric oxide deficient hypertensive rats. Aim and Objectives: To find out the effect of cilnidipine, L/N-type calcium channel blocker on oxidative stress of kidney in Nitric Oxide Synthase (NOS) inhibited experimental hypertensive rats. Material and Methods: Male Albino Wistar rats (n-24) were randomly allocated into four groups: Group 1 control received vehicle; Group 2 received Cilnidipine; Group 3 received N-G-nitro-L-Arginine Methyl Ester NAME) hydrochloride; Group 4 received L-NAME and Cilnidipine; All drugs are given orally for 4 weeks. Blood pressure was measured before and after intervention and twice during intervention for all the rats. On 29th day, blood was collected and animals were sacrificed and kidneys were collected. Serum and kidney tissue Malondialdehyde (MDA) levels are estimated. Results: The results demonstrate that there is a significant increase in Mean Arterial Pressure (MAP) in L-NAME treated rats compared to control group. Treatment with cilnidipine significantly decreases the MAP in Group 4 rats. We also demonstrated the significant elevated serum and kidney tissue MDA levels in L-NAME treated rats. Treatment with Cilnidipine reduced serum and kidney tissue MDA levels in Group 4 rats as compared to Group 3 rats. Conclusion: The results demonstrate that cilnidipine has suppressive effects against progressive renal injury as evidenced by decrease oxidative stress indicator MDA levels in NO deficient hypertensive rats. This effect is explained by the L/N type calcium channel inhibition of Cilnidipine, the L-type calcium channel blocking action lowers blood pressure and N-type calcium channel blocking action leads to suppression of the sympathetic nerve activity and renin-angiotensin aldosterone system.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 50 条
  • [1] Antiproteinuric effect of an N-type calcium channel blocker, cilnidipine
    Tsuchihashi, T
    Ueno, M
    Tominaga, M
    Kajioka, T
    Onaka, U
    Eto, K
    Goto, K
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2005, 27 (08) : 583 - 591
  • [2] Comparison of a negative dromotropic effect of L/N-type calcium channel blocker cilnidipine with that of L-type blocker nicardipine.
    Sugiyama, A
    Satoh, Y
    Nakamura, Y
    Hashimoto, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 144P - 144P
  • [3] Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats
    Aritomi, Shizuka
    Harada, Eri
    Sugino, Kazumi
    Nishimura, Mai
    Nakamura, Tarou
    Takahara, Akira
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (04) : 344 - 352
  • [4] Effects of the L- and N-type calcium channel blocker cilnidipine on growth of vascular smooth muscle cells from spontaneously hypertensive rats
    Hu, WY
    Fukuda, N
    Su, JZ
    Kanmatsuse, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (03) : 450 - 459
  • [5] L/N type calcium channel blocker, cilnidipine, attenuates post-infarct cardiac remodeling in hypertensive rats
    Mochizuki, Kaori
    Kobara, Miyuki
    Ohigashi, Makoto
    Toba, Hiroe
    Nakata, Tetsuo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S241 - S241
  • [6] Vasodilatory Effect of Cilnidipine, an L-type and N-type Calcium Channel Blocker, on Rat Kidney Glomerular Arterioles
    Konno, Yuusuke
    Kimura, Kenjiro
    INTERNATIONAL HEART JOURNAL, 2008, 49 (06) : 723 - 732
  • [7] Altered calcium signaling in platelets from nitric oxide-deficient hypertensive rats
    Iyú D.
    Atucha N.M.
    Martínez-Prieto C.
    Ortiz M.C.
    García-Estañ J.
    Cell Communication and Signaling, 2 (1)
  • [8] Cardioprotective effect of an L/N-type calcium channel blocker in patients with hypertensive heart disease
    Kosaka, Toshimitsu
    Nakagawa, Masayasu
    Ishida, Masaru
    Iino, Kenji
    Watanabe, Hiroyuki
    Hasegawa, Hitoshi
    Ito, Hiroshi
    JOURNAL OF CARDIOLOGY, 2009, 54 (02) : 262 - 272
  • [9] EFFECT OF L- AND N-TYPE CALCIUM CHANNEL BLOCKER CILNIDIPINE ON SERUM SOLUBLE (PRO)RENIN RECEPTOR CONCENTRATION
    Watanabe, Daisuke
    Morimot, Satoshi
    Ichihara, Atsuhiro
    JOURNAL OF HYPERTENSION, 2021, 39 : E220 - E220
  • [10] Pressure natriuresis in nitric oxide-deficient hypertensive rats:: Effect of antihypertensive treatments
    Fortepiani, LA
    Rodrigo, E
    Ortíz, MC
    Cachofeiro, V
    Atucha, NM
    Ruilope, LM
    Lahera, V
    García-Estañ, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1999, 10 (01): : 21 - 27